![Rainer Metzger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Jean-François Brepson | M | - |
PathoQuest SAS
![]() PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Christiane Honisch | M | - |
PathoQuest SAS
![]() PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | 6 años |
Arne C. Faisst | M | - |
4D Lifetec AG
![]() 4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 10 años |
Nick Mijnssen | M | - |
4D Lifetec AG
![]() 4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 10 años |
Thierry Laugel | M | 57 |
PathoQuest SAS
![]() PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Jean-Pascal Beaufret | M | 73 |
PathoQuest SAS
![]() PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Marco Zingg | M | - |
4D Lifetec AG
![]() 4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 5 años |
Laurent Lafferrère | M | - |
PathoQuest SAS
![]() PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Francia | 5 | 62.50% |
Suiza | 3 | 37.50% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Rainer Metzger
- Red Personal